Investigational Drug Information for Gliolan
✉ Email this page to a colleague
What is the development status for investigational drug Gliolan?
Gliolan is an investigational drug.
There have been 17 clinical trials for Gliolan.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Glioblastoma, Brain Neoplasms, and Glioma. The leading clinical trial sponsors are photonamic GmbH & Co. KG, Westfälische Wilhelms-Universität Münster, and Constantinos Hadjipanayis.
Summary for Gliolan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 271 |
| WIPO Patent Applications | 153 |
| Japanese Patent Applications | 34 |
| Clinical Trial Progress | Phase 3 (2010-11-01) |
| Vendors | 67 |
Recent Clinical Trials for Gliolan
| Title | Sponsor | Phase |
|---|---|---|
| Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor | photonamic GmbH & Co. KG | Phase 1/Phase 2 |
| Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor | Westfälische Wilhelms-Universität Münster | Phase 1/Phase 2 |
| Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma | Hemerion Therapeutics | Phase 2 |
Clinical Trial Summary for Gliolan
Top disease conditions for Gliolan
Top clinical trial sponsors for Gliolan
US Patents for Gliolan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
